Restricted accessResearch articleFirst published online 1997-1
Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems
Ahern D.K., Gorkin L., Anderson J.L., Tierney C., Hallstrom A., Ewart C., Capone R.J., Schron E., Kornfeld D., Herd J.A. (1990) Biobehavioural variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am Cardiol66: 59-62
2.
Askelrod S.D., Gordon G., Ubel A.F., Shannon D.C., Barger CA, Cohen R.J. (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science213: 220-222
3.
Bailey J.E., Potokar J., Coupland N.J., Nutt D.J. (1995) The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man. J Psychopharmac9: 137-141
4.
Balogh S., Fitzpatrick D.F., Hendricks S.E., Paige S.R. (1993) Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmac Bull29: 201-206
5.
Bannister S.J., Houser V.P., Hulse J.D., Kisicki J.C., Rasmussen J.G. (1989) Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin and digoxin. Acta Psychiat Scand80 (Suppl.): 102-106
6.
Bench C.J., Friston K.J., Brown R.G., Frackowiak R S J, Dolan R.J. (1993) Regional cerebral blood flow in depression measured by positron emmission tomography: the relationship with clinical dimensions . Psychol Med23: 579-590
7.
Benfield P., Ward A. ( 1986) Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs32: 313-334
8.
Bergstrom R.F., Lemberger L., Farid N.A., Wolen R.L. (1988) Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychiat153 (Suppl. 3): 47-50
9.
Bigger J T J, Giardina EG V, Perel J.M., Kantor S.J., Glassman A.H. (1977) Cardiac antiarrhythmic effect of imipramine hydrochoride . N Engl J Med296: 206-208
10.
Blier P., Bergeron R. (1995) The safety of concomitant use of sumatriptan and antidepressant treatments. J Clin Psychopharmac15: 106-109
11.
Boakes A.J., Laurence D.R., Teoh P.C., Barar F.S., Benedikter L.T., Prichard B.N. (1973) Interactions between sympathomimetic amines and antidepressant agents in man. BMJ1: 311-315
12.
British National Formulary (1992) The Pharmaceutical Press: London, p. 468
13.
Brosen K., Sjelbo E., Rasmussen B.B. (1993) Fluvoxamine is a potent inhibitor of cytochrome P450IA2. Biochem Pharmac45: 1211-1214
14.
Cannon R.O., Quyyumi A.A., Mincemoyer R. (1994) Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med330: 1411-1417
15.
Carney R.M., Rich M.W., Freedland K.E., Saini J., te Velde A., Simeone C., Clark K. (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med50: 627-633
16.
Casadei B., Piplis A., Sessa F., Conway J., Sleight P. (1993) Low dose of scopolamine increases cardiac vagal tone in the acute phase of myocardial infarction. Circulation88: 353-357
17.
Celada P., Dolera M., Alvarez E., Artigas F. (1992) Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients . J Affect Dis25: 243-250
18.
Christensen P., Thomsen H.Y., Pedersen O.L., Gram L.F., Kragh-Sorensen P. (1985) Orthostatic side effects of clomipramine and citalopram during treatment for depression. Psychopharmacology86: 383-385
19.
Coats A J S, Adamopoulos S., Radaelli A., McCance A., Meyer T.E., Bernardi L., Solda P.L., Davey P., Ormerod O., Forfar C. (1992) Controlled trial of physical training in heart failure. Exercise performance, hemodynamics, ventilation and autonomic failure . Circulation85: 2119-2131
20.
Coull D.S., Crooks J., Dingwall-Fordyce K. (1970) A method of monitoring drugs for adverse reaction. II. Amitriptyline and cardiac disease. Eur J Clin Pharmac3: 51-55
21.
Coupland N.J., Wilson S.J., Bailey J.E., Potokar J., Nutt D.J. (1994) A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability . Eur Neuropsychoparmac4: 294-295 (abstract)
22.
Coupland N.J., Wilson S.J., Potokar J.P., Bell C.E., Bailey J.E., Nutt D.J. (1995a) A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmac10: 229-238
23.
Coupland N.J., Bailey J.E., Wilson S.J., Horvath R., Nutt D.J. (1995b) The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clin Autonom Res5: 171-177
24.
Coupland N.J., Bailey J.E., Potokar J., Bell CE, Lillywhite A.R., Nutt D. ( 1995c) Abnormal cardiovascular responses to standing in patients with panic disorder and social phobia. J Psychopharmac9 (Suppl.): A19 (Abstract)
25.
Cusack B., Nelson A., Richelson E. (1994) Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology114: 559-565
26.
Dalack G.W., Roose S.P. (1991) Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiat51 (Suppl. 7): 4-9
27.
De Mey C., Schroeter V., Butzer R., Roll S., Belz G.G. (1995) Method specificity of non-invasive blood pressure measurement: oscillometry and finger pulse methods vs acoustic methods. Br J Clin Pharmac40: 291-297
28.
Dimier-David L., Billon N., Costagliola D., Jaillon P., Funck-Brentano C. (1994) Reproducibility of non-invasive measurement and of short-term variability of blood pressure and heart rate in healthy volunteers . Br J Clin Pharmac38: 109-115
29.
Eckberg D.L., Drabinsky M., Braunwald E. (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med285: 877-883
30.
Ewing D.J., Campbell I.W., Clarke B.F. (1980) Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med92: 308-311
31.
Feder R. (1991) Bradycardia and syncope induced by fluoxetine. J Clin Psychiat52: 138-139
32.
Ferguson J., Khan A., Kucharik R., Leventer S., Cucci C. (1994) A placebo-controlled comparative study of the effects on blood pressure and antidepressant efficacy of venlafaxine and imipramine . Neuropsychopharmacology10: 165S(abstract)
33.
Fisch C. (1985) Effect of fluoxetine on the ECG. J Clin Psychiat46: 42-44
34.
Fisch C., Knoebel S.B. (1992) ECG findings in sertraline depression trials. Drug Invest4: 305-312
35.
Frasure-Smith N., Lesperance F., Talajic M. (1993) Depression following myocardial infarction: impact on 6 month survival. JAMA270: 1819-1825
36.
Fritze J., Unsorg B., Lanczik M. (1991) Interaction between carbamazepine and fluvoxamine . Acta Psychiat Scand84: 583-584
37.
Glassman A.H., Bigger J.T. Jr (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Archs Gen Psychiat38: 815-820
38.
Glassman A.H., Johnson L.L., Giardina E G V, Walsh B.T., Roose S.P., Cooper T.B., Bigger J.T. Jr (1983) The use of imipramine in depressed patients with congestive cardiac failure. JAMA250: 1997-2001
39.
Glassman A.H., Roose S.P., Bigger J.T. (1993) The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered. JAMA269: 2673-2675
40.
Goulet J., Perusse R., Turcotte J. (1992) Contraindications to vasoconstrictors in dentistry: part III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol74: 692-697
41.
Green A.R. (1990) The effects of antidepressant drugs on noradrenergic receptor mechanisms in the central nervous system. In Heal D J, Marsden CA (eds), The pharmacology of noradrenaline in the central nervous system. Oxford University Press, Oxford, pp. 316-348
42.
Greenblatt D.J., Preskorn S.H., Cotreau M.M., Horst W.D., Harmatz J.S. (1992) Fluoxetine impairs clearance of alprazolam but not of clonazepam. Clin Pharmac Ther52: 479-486
43.
Grossman P., Karemaker J., Wieling W. (1991) Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control. Psychophysiology28: 201-216
44.
Grubb B.P., Samoil D., Kosinski D., Kip K., Brewster P. (1994a) Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol24: 490-494
45.
Grubb B.P., Samoil D., Kosinski D., Wolfe D., Lorton M., Madu E. ( 1994b) Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension. Am J Med97: 366-368
46.
Gundersen H J G, Neubauer B. (1977) A long-term diabetic autonomic nervous abnormality . Diabetalogia13:137-140
47.
HarveyA T., Preskorn S.H. (1995) Interactions of serotonin reuptake inhibitors with tricyclic antidepressants. Archs Gen Psychiat52: 783-784
48.
Hayward C., Clark D.B., BarrTaylor C. (1990) Panic disorder, anxiety, and cardiovascular risk . In BallengerJ C (ed.), Clinical aspects of panic disorder. Wiley-Liss, New York, pp. 99-110
49.
Hillis L.D., Lange R.A. (1991) Serotonin and acute ischaemic heart disease. N Engl J Med324: 688-689
50.
Holliday S.M., Benfield P. (1995) Venlafaxine: a review of its pharmacology and therapeutic potential in depression. Drugs49: 280-294
51.
Imholz B P M, Settels J.J., van der Meiracker A.H., Wesseling K.H., Wieling W. (1990) Non-invasive continuous finger blood pressure measurement during orthostatic stress compared to intraarterial pressure. Cardiovasc Res24: 214-221
Jakobsen J., Hauksson P., Vestergaard P. (1984) Heart rate variation in patients treated with antidepressants, an index of anticholinergic effects. Psychopharmacology84: 544-548
54.
Kleiger R.E., Miller A.B., Bigger J.T., Moss A.J. (1987) Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol59: 256-262
55.
Klein E., Cnaani E., Harel T., Braun S., Ben-Haim S. (1995) Altered heart rate variability in panic disorder patients. Biol Psychiat37: 18-24
56.
Kobinger W., Walland A. (1971) Involvement of adrenergic receptors in central vagus activity. Eur J Pharmac16: 120-122
57.
Levenson J.L., Hamer R.M., Rossiter L.F. (1990) Relation of psychopathology in general medical inpatients to use and costs of service. Am J Psychiat147: 1498-1503
58.
Lin K., Poland R.E. (1995) Ethnicity, culture and psychopharmacology. In Bloom F E, Kupfer D J (eds), Psychopharmacology: the fourth generation of progress. Raven Press, New York , pp.1907-1917
Mangano D.T., Browner W.S., Hollenberg M., Li J., Tateo I.M. (1992) Long-term prognosis following non-cardiac surgery . JAMA268: 233-239
61.
McCall R.B., Clement M.E. (1994) Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmac Rev46: 231-243
62.
Middleton H.C., Nutt D.J. (1988) Heart rate response to standing as an index of adaptation to imipramine during treatment of panic disorder. Hum Psychopharmac3: 191-194
63.
Middleton H.C., Nutt D.J., Anastassiades P. (1988) Evidence that imipramine-induced postural hypotension may be centrally mediated. Hum Psychopharmac3: 181-190
64.
Middleton H.C., Ashby M., Robbins T.W. (1994) Reduced plasma noradrenaline and abnormal heart rate variability in resting panic disorder patients. Biol Psychiat36: 847-849
65.
Montgomery S.A., Kasper S. (1995) Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmac9 (Suppl. 4): 33-40
66.
Mukerji V., Beitman B.D., Alpert M.A., Hewett J.E., Basha I.M. (1987) Panic attack symptoms in patients with chest pain and angiographically normal coronary arteries. J Anx Dis1: 41-46
67.
Ottervanger J.P., van Witsen T.B., Valkenberg H.A., Stricker B.H. (1993) Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. BMJ307: 1185
68.
Overo K.F. (1989) The pharmacokinetic and safety evaluation of citalopram from preclinical and clinical data. In Montgomery S A (ed.), Citalopram, a new antidepressant from Lundbeck. Proceedings of XXII Nordiske Psykiater Kongres Reykjavik. Excerpta Medica, Amsterdam, pp. 22-30
69.
Pfeifer M.A., Cook D., Brodsky J., Tice D., Reenan A., Sedine S., Halter J.B., Porte D. Jr (1982) Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic men. Diabetes31: 339-345
70.
Pozzati A., Pancaldi L.G., Bugiardini R. (1994) Transient sympathovagal unbalance triggers 'ischaemic' sudden death during Holter monitoring. Circulation90: I-330 (abstract)
71.
Preskorn S. (1993) Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiat54 (Suppl. 9): 14-34
72.
Preskorn S.H., Alderman J., Chung M., Harrison W., Messig M., Harris S. (1994) Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmac14: 90-98
73.
Rathmann W., Ziegler D., Jahnke M., Haastert B., Gries F.A. (1993) Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diab Med10: 820-824
74.
Rechlin T. (1994) The effect of amitriptyline, doxepine, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmac14: 392-395
75.
RechlinT., Claus D.,Weis M. ( 1994a) Heart rate analysis in 24 patients treated with 150 mg amitriptyline per day. Psychopharmacology116: 110-114
76.
Rechlin T., Weis M., Spitzer A., Kaschka W.P. (1994b) Are affective disorders associated with alterations of heart rate variability? J Affect Dis32: 271-275
77.
Roose S.P., Glassman A.H., Siris S.G., Walsh B.T., Bruno R.L., Wright L.B. (1981) Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. J Clin Psychopharmac1: 316-319
78.
Roose S.P., Glassman A.H., Giardina E G V, Walsh B.T., Woodring S., Bigger J.T. (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Archs Gen Psychiat44: 273-275
79.
Rosen S.D., Paulesen E., Frith C.D., Frackowiak R.S., Davis G.J., Jones T., Camici P.G. (1994) Central nervous pathways mediating angina pectoris . Lancet344: 147-150
80.
Rosen S.D., Paulesen E., Frackowiak R.S., Camici P.G. (1995) Central correlates of chest pain in syndrome X . Circulation92: 1651
81.
Rudorfer M.V., Young R.C. (1980) Desipramine: cardiovascular effects and plasma levels. Am J Psychiat137: 984-986
82.
Samoil D., Grubb B.P. (1992) Vasovagal (neurally mediated) syncope: pathophysiologic aspects. Eur J Pacing Electrophysiol2: 234-241Saxena P.R., Villalon CM (1991) 5-HT: a chameleon in the heart. Trends Pharmac Sci121: 223-227
83.
Schleifer S.J., Macari-Hinson M.M., Coyle D.A. (1989) The nature and course of depression following myocardial infarction. Arch Intern Med149: 1785-1789
84.
Shrivastava R.K., Cohn C., Crowder J., Davidson J., Dunner D., Feighner J., Kiev A., Patrick R. (1994) Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmac14: 322-329
85.
Smyth H.S., Sleight P., Pickering G.W. (1969) Reflex regulation of arterial blood pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Circ Res24: 109
86.
Sprangers R L H, Wesseling K.H., Imholz A L T, Imholz B P M, Wieling W. (1991) The initial blood pressure fall upon stand up and onset to exercise explained by changes in total peripheral resistance. J Appl Physiol70: 523-530
87.
Steptoe A., Vogele C. (1990) Cardiac baroreflex function during postural change assessed using non-invasive spontaneous sequence analysis in young men. Cardiovasc Res24: 627-632
88.
Sternbach H. (1991) Fluoxetine associated potentiation of calcium-channel blockers. J Clin Psychopharmac11: 390-391
89.
Szabadi E., Gaszner P., Bradshaw C.M. (1980) The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers . Br J Psychiat137: 433-439
90.
Szabadi E., Lister B.S., Bradshaw C.M. (1990) Effect of chronic treatment with desipramine on peripheral beta-receptor-mediated responses in man. Eur J Pharmac183: 161-162(abstract)
91.
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1991) The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation84: 1831-1851
92.
Taylor D. (1995) Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination: interactions and therapeutic uses. Br J Psychiat167: 575-580
93.
Thomson A.H., McGovern E.M., Bennie P., Caldwell G., Smith P. (1992) Interaction between fluvoxamine and theophylline . Pharmaceut J1: 137
94.
Townend J.N., Littler W.A. (1995) Cardiac vagal activity: a target for intervention in heart disease. Lancet345: 937-938
95.
Tulen J H M, de Man K.J., Bruijn J.A., Pepplinkhuizen L., van den Meiracker A.H. , Man in't Veld A.J. (1994) Spectral analysis of fluctuations in heart rate and blood pressure before and after treatment with imipramine or mirtazepine in major depressive disorder. Eur Neuropsychoparmac4: 328-329(abstract)
96.
Van Dellen H.J., Aasman J., Mulder L J M, Mulder G. (1985) Time domain versus frequency domain measures of heart rate variability. In Orlebeke J F, Mulder G, van Doornen L J P (eds), The psychophysiology of cardiovascular control . Plenum, New York, pp.353-374
97.
Veith R.C., Friedel R.O., Bloom V., Bielski R. (1980) Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmac Therap27: 796-802
98.
Veith R.C., Raskin M.A., Caldwell J.H., Barnes R.F., Gumbrecht G., Ritchie J.L. (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med306: 954-959
99.
Verheyen A., Vlaminckx E., Geuens G., De Clerck F. (1994) Does 5-hydroxytryptamine contribute to neointimal proliferation in response to balloon-induced arterial injury in rats? J Serotonin Res1: 79-84
100.
Vybiral T., Bryg R.J., Maddens M.E. (1990) Effects of transdermal scopolamine on heart rate variability in normal subjects. Am J Cardiol65: 604-608
101.
WalleyT., Pirmhamed M., Proudlove C., Maxwell D. (1993) Interaction of metoprolol and fluoxetine. Lancet341: 967-968
102.
Warrington S.J., Dana-Hari J., Sinclair A.J. (1989) Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison study with amitriptyline and placebo in healthy men. Acta Psychiat Scand80 (Suppl. 350): 42-44
103.
Wells K.B., Golding J.M., Burnham M.A. (1988) Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiat145: 976-981
104.
Wells K.B., Stewart A., Hays R.D., Burnam M.A., Rogers W., Daniels M., Berry S., Greenfield S., Ware J. ( 1989) The functioning and well-being of depressed patients. JAMA262: 914-919
105.
Wieling W. (1992) Non invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In Bannister R, Mathias C J (eds), Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, Oxford, pp. 291-311
106.
Wilner K.D., Lzar J.D., Apseloff G. (1991) The effects of sertraline on the pharmacodynamics of warfarin in healthy volunteers. Biol Psychiat29: 354S-355S(abstract)
107.
Wilson S.J., Lillywhite A.R., Coupland N.J., Potokar J., Bailey J.E., Nutt D. ( 1993) Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standing. Eur Neuropsychopharmac3: 440-441 (abstract)
108.
Wilson W.H., Higano H., Papadatos Y., Kelwala S., Ban T.A. (1983) A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers. Br J Clin Pharmac15: 385S-392S
109.
Wise M.G., Taylor S.E. (1990) Anxiety and mood disorders in medically ill patients . J Clin Psychiat51: 27-32
110.
Woolfrey S., Gammack N.S., Dewar M.S., Brown P J E (1993) Fluoxetine-warfarin interaction. BMJ307: 241
111.
Yeragani V.K., Meiri P., Balon R., Pohl R., Golec S. (1990) Effect of imipramine treatment on changes in heart rate and blood pressure during postural and isometric handgrip tests. Eur J Clin Pharmac38: 139-144
112.
Yeragani V.K., Pohl R., Balon R., Ramesh C., Glitz D., Jung I., Sherwood P. (1991) Heart rate variability in patients with major depression . Psychiat Res37: 35-46
113.
Yeragani V.K., Pohl R., Balon R., Ramesh C., Glitz D., Weinberg P., Merlos B. (1992a) Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology26: 27-32
114.
Yeragani V.K., Berger R., Pohl R., Srinivasan K., Balon R., Ramesh C., Weinberg P., Berchou R. (1992b) Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmac20: 609-618
115.
Yeragani V.K., Pohl R., Berger R.Balon R., Ramesh C., Glitz D., Srinavsan K., Weinberg P. (1993) Decreased heart rate variability in panic disorder patients: a study of power spectral analysis of heart rate. Psychiat Res46: 89-103
116.
Yeragani V.K., Srinivasan K., Pohl R., Berger R., Balon R., Ramesh C. (1994) Effects of nortriptyline on heart rate variability in panic disorder patients: a preliminary study using power spectral analysis of heart rate. Neuropsychobiology29: 1-7